Skip to main content

Year: 2022

Brandywine Realty Trust to Redeem All Outstanding 3.95% Guaranteed Notes due 2023

PHILADELPHIA, Dec. 21, 2022 (GLOBE NEWSWIRE) — Brandywine Realty Trust (the “Company”) (NYSE:BDN) announced today that its operating partnership, Brandywine Operating Partnership, LP (the “Operating Partnership”), intends to redeem all of the outstanding 3.95% Guaranteed Notes due February 15, 2023 (the “Notes”) issued by the Operating Partnership and not purchased pursuant to its previously announced tender offer for such Notes. The expected redemption date will be January 20, 2023 (the “Redemption Date”). The Notes will be redeemed at a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to the Redemption Date. From and after the Redemption Date and the payment of the redemption price, interest will cease to accrue, and on and...

Continue reading

SalMar – 2022 share-based incentive scheme for senior executives and key personnel

In accordance with the authorization granted by the AGM on 8 June 2022, the board of directors of SalMar ASA has decided to establish a share-based incentive scheme (Restricted Share Unit Plan) for senior executives and key personnel employed by the company and its subsidiaries. The scheme encompasses up to 250 000 shares and has a duration of three years. The company’s liability with respect to the scheme will be met through existing holdings of treasury shares. As of 21 December 2022, SalMar ASA holds 14 286 treasury shares. The purpose of the share-based incentive scheme (RSUP) is to encourage employees to maintain a deep, long-term engagement in the company, through a further alignment of the employees’ interests with those of other shareholders. Under the RSUP, participating individuals will be awarded shares to motivate...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 21 December 2022

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 21.12.2022 at 18.45 EET   Rovio Entertainment Corporation – Repurchase of own shares on 21.12.2022   Rovio Entertainment Corporation  In the Nasdaq Helsinki  Date 21.12.2022Exchange transaction BUYShare trading code ROVIOAmount, shares 25111Average price/share, EUR 6,052077Total cost, EUR 151973,72      Rovio now holds a total of 6 806 617 shares including the shares repurchased on 21.12.2022   On behalf of Rovio Entertainment Corporation     OP Corporate Bank PLC  Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Continue reading

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum

Saint-Herblain (France), December 21, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold investor meetings during the 41st Annual J.P. Morgan Healthcare Conference, January 9 – 12, 2023 in San Francisco and the Oddo BHF Forum, January 5 – 6, 2023 in Lyon France. Valneva’s CEO and CFO will notably discuss the Company’s current vaccine pipeline and commercial products as well as highlight Valneva’s core near- and mid-term value drivers, including its Lyme disease vaccine candidate VLA15 (Phase 3, partnered with Pfizer) and its single shot chikungunya virus vaccine candidate VLA1553 (rolling submission of biologics license application underway). To schedule a 1on1 investor meeting with...

Continue reading

Ferrellgas Introduces Newsroom to Provide Timely Customer Reminders & Information

LIBERTY, Mo., Dec. 21, 2022 (GLOBE NEWSWIRE) — Today is the first day of winter, and Ferrellgas Partners, L.P. (OTC: FGPR), one of the nation’s largest propane retailers, wants to make sure America’s propane homeowners are prepared for whatever Old Man Winter brings this year. Winter is never easy to predict, but it typically brings at least a blast or two of cold temperatures. That’s where Ferrellgas propane plays a big role. As a company that’s been in business for more than eight decades, Ferrellgas understands the importance of educating its customers about propane and their responsibilities as propane homeowners. With the launch of a Newsroom on the Ferrellgas website, the company has doubled down on that important commitment. “We couldn’t think of a better day to launch our Newsroom than on the first day of winter,” Vice...

Continue reading

Results From the Annual and Special Shareholders Meeting

ROUYN-NORANDA, Quebec, Dec. 21, 2022 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX VENTURE: ABI) is pleased to announce the results of its Annual and Special meeting of shareholders held on December 20, 2022 (“the Meeting”). The shareholders elected each of the nominees presented in the management circular relating to the Meeting, namely: Pascal Hamelin Chief Executive Officer since April 2022, Daniel Adam, René Branchaud, Renaud Hinse, François Mestrallet, Nicole Veilleux and Loïc Bureau. Pascal Hamelin and Loïc Bureau are new directors of the Corporation. Loïc Bureau holds a bachelor’s degree in geological engineering and has more than 20 years of experience in mining exploration, project management and teaching. He is recognized as an adaptive, resourceful and goal-oriented manager. The Board...

Continue reading

Tryp Therapeutics to Present at Biotech Showcase on Monday, January 9, 2023

Company to be in San Francisco January 8-11, 2023, during 41st Annual J.P. Morgan Health Care Conference KELOWNA, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced that the Company will be presenting at the Biotech Showcase on Monday, January 9, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA. Time: 11:00am PSTTrack: Yosemite C (Ballroom Level) Biotech Showcase is an investor conference featuring insights from top investors and biopharma executives. Interested parties can register to attend the event here: https://informaconnect.com/biotech-showcase/registration-options/ Additionally,...

Continue reading

Wallbridge Receives $15.9 Million of Quebec Refundable Investment Tax Credits

TORONTO, Dec. 21, 2022 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM, OTCQX:WLBMF) (“Wallbridge” or the “Company”) is pleased to report that it received $15.9 million of cash refunds with respect to its 2021 Quebec Tax Credit Relating to Resources (TCRR) and Quebec Refundable Duties Credit for Losses (RDCL) that were claimed on its 2021 Quebec income and mining tax returns. The amount received for the TCRR and the RDCL represents an interim advance on the $20.0 million of Quebec investment tax credits claimed and Wallbridge expects the balance, subject to audit adjustments, to be received in the first quarter of 2023 once the audit has been completed. Marz Kord, Wallbridge’s President, and CEO, commented: “The receipt of the Quebec investment tax credits provides a significant portion of funding for our 2023 program...

Continue reading

Awilco Drilling PLC: Contemplated Private Placement

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR HONG KONG, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Aberdeen, 21st December 2022 Awilco Drilling Plc (“Awilco Drilling” or the “Company”) is contemplating a private placement of new Sponsored Norwegian Depository Receipts (the “Offer Shares” or “New Shares”) raising gross proceeds up to the NOK equivalent of up to USD 8 million (the “Private Placement” or the “Offering”). The Company has received pre-subscriptions from existing shareholders amounting to USD 4.2 million, including inter alia pre-subscriptions...

Continue reading

CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million

CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —  CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging leader in development and operation of ultramodern, highly efficient cannabis grow facilities, announced today Health Canada has issued a cultivation license to the Company. As a result, CannaPharmaRx may now legally grow cannabis and sell its crop to other licensed producers and licensed wholesalers throughout Canada. Health Canada is the department of the federal government of Canada responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires that all cannabis products meet federal regulatory requirements before they can be sold in Canada. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.